Chromosome stability in tonsillar squamous cell carcinoma is associated with HPV16 integration and indicates a favorable prognosis

International Journal of Cancer

Volumn 132, Issue 8, 2013, Pages 1781-1789

  Mooren, Jeroen J ^a   Kremer, Bernd ^a   Claessen, Sandra M H ^a   Voogd, Adri C ^a   Bot, Fredrik J ^a   Peter Klussmann, J ^b   Huebbers, Christian U ^c   Hopman, Anton H N ^a   Ramaekers, Frans C S ^a   Speel, Ernst Jan M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Jean Uhrmacher Institute for Otorhinolaryngological Research   (Germany)

Author keywords

chromosome instability; oropharyngeal carcinoma; prognosis

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE FREE SURVIVAL; DISOMY; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; POLYPLOIDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOKING; SQUAMOUS CELL CARCINOMA; TONSIL CARCINOMA; VIRUS DNA CELL DNA INTERACTION;

CARCINOMA, SQUAMOUS CELL; CHROMOSOMAL INSTABILITY; DNA PROBES; HUMAN PAPILLOMAVIRUS 16; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PROGNOSIS; TONSILLAR NEOPLASMS; VIRUS INTEGRATION;

EID: 84873994816     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27846     Document Type: Article

References (51)

1. Aguilera A, Gõmez-González B,. Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet 2008; 9: 204-17.
2. Abou-Elhamd KE, Habib TN,. The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma. Oral Oncol 2007; 43: 366-72.
3. Mahmood JU, Suzuki K, Nomura T, et al. The implication of DNA content and S-phase fraction in oral carcinomas with and without metastasis. Int J Oral Maxillofac Surg 1995; 24: 427-32.
4. Bockmuhl U, Wolf G, Schmidt S, et al. Genomic alterations associated with malignancy in head and neck cancer. Head Neck 1998; 20: 145-51.
5. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-92.
6. Soder AI, Hopman AH, Ramaekers FC, et al. Distinct nonrandom patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck. Cancer Res 1995; 55: 5030-7.
7. Morrison LE, Jacobson KK, Friedman M, et al. Aberrant EGFR and chromosome 7 associate with outcome in laryngeal cancer. Laryngoscope 2005; 115: 1212-8.
8. Veltman JA, Bot FJ, Huynen FC, et al. Chromosome instability as an indicator of malignant progression in laryngeal mucosa. J Clin Oncol 2000; 18: 1644-51.
9. Bergshoeff VE, Hopman AH, Zwijnenberg IR, et al. Chromosome instability in resection margins predicts recurrence of oral squamous cell carcinoma. J Pathol 2008; 215: 347-8.
10. Fleskens SJHM, Takes RP, Otte-Höller I, et al. Simultaneous assessment of DNA ploidy and biomarker expression in paraffin-embedded tissue sections. Histopathology 2010; 57: 14-26.
11. Taoudi Benchekroun M, Saintigny P, Thomas SM, et al. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res (Phila) 2010; 3: 800-9.
12. Hafkamp HC, Manni JJ, Speel EJ,. Role of human papillomavirus in the development of head and neck squamous cell carcinomas. Acta Otolaryngol 2004; 124: 520-6.
13. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-47.
14. Chen TM, Pecoraro G, Defendi V,. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res 1993; 53: 1167-71.
15. Lace MJ, Anson JR, Klingelhutz AJ, et al. Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs. J Virol 2009; 83: 11784-94.
16. Pecoraro G, Lee M, Morgan D, et al. Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells. Am J Pathol 1991; 138: 1-8.
17. Kim MS, Shin KH, Baek JH, et al. HPV-16, tobacco-specific N-nitrosamine, and N-methyl-N'-nitro-N-nitrosoguanidine in oral carcinogenesis. Cancer Res 1993; 53: 4811-6.
18. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-20.
19. Hafkamp HC, Speel EJM, Haesevoets A, et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 2003; 107: 394-400.
20. Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001; 92: 2875-84.
21. Duensing S, Münger K,. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 2004; 109: 157-62.
22. Patel D, Incassati A, Wang N, et al. Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M-phase proteins. Cancer Res 2004; 64: 1299-306.
23. White AE, Livanos EM, Tlsty TD,. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 1994; 8: 666-77.
24. Southern SA, Noya F, Meyers C, et al. Tetrasomy is induced by human papillomavirus type 18 E7 gene expression in keratinocyte raft cultures. Cancer Res 2001; 61: 4858-63.
25. Xiong Y, Kuppuswamy D, Li Y, et al. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation. J Virol 1996; 70: 999-1008.
26. Hopman AHN, Smedts F, Dignef W, et al. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol 2004; 202: 23-33.
27. Hopman A, Theelen W, Hommelberg P, et al. Genomic integration of oncogenic HPV and gain of the human telomerase geneTERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol 2006; 210: 412-9.
28. Hausen zur H,. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-50.
29. Andl T, Kahn T, Pfuhl A, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998; 58: 5-13.
30. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-56.
31. Hafkamp HC, Manni JJ, Haesevoets A, et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008; 122: 2656-64.
32. Mellin H, Friesland S, Lewensohn R, et al. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 2000; 89: 300-4.
33. Hafkamp HC, Mooren JJ, Claessen SM, et al. P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol 2009; 22: 686-98.
34. Shanmugaratnam S,. Histologic typing of tumors of the upper respiratory tract and ear. Geneva (Switzerland): World Health Organization, 1991.
35. Hopman AH, Kamps MA, Speel EJ, et al. Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma. Am J Pathol 2002; 161: 1119-25.
36. Marur S, D'Souza G, Westra WH, et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010; 11: 781-9.
37. Braakhuis BJ, Snijders PJ, Keune WJ, et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 2004; 96: 998-1006.
38. Agrawal N, Frederick MJ, Pickering CR, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011; 333: 1154-7.
39. Heselmeyer K, Schrock E, Manoir du S, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996; 93: 479-84.
40. Klussmann JP, Mooren JJ, Lehnen M, et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 2009; 15: 1779-86.
41. Jung AC, Briolat J, Millon R, et al. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer 2010; 126: 1882-94.
42. Sartor MA, Dolinoy DC, Jones TR, et al. Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis. Epigenetics 2011; 6: 777-87.
43. Yang N, Nijhuis ER, Volders HH, et al. Gene promoter methylation patterns throughout the process of cervical carcinogenesis. Cell Oncol 2010; 32: 131-43.
44. Stenner M, Yosef B, Huebbers CU, et al. Nuclear translocation of β-catenin and decreased expression of epithelial cadherin in human papillomavirus-positive tonsillar cancer: an early event in human papillomavirus-related tumor progression? Histopathology 2011; 58: 1117-26.
45. Tammela T, Alitalo K,. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010; 140: 460-76.
46. Southern SA, Evans MF, Herrington CS,. Basal cell tetrasomy in low-grade cervical squamous intraepithelial lesions infected with high-risk human papillomaviruses. Cancer Res 1997; 57: 4210-3.
47. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008; 26: 3128-37.
48. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
49. Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120: 1731-8.
50. Egelmeer AGTM, Velazquez ER, de Jong JMA, et al. Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients. Radiother Oncol 2011; 100: 108-15.
51. Maxwell JH, Kumar B, Feng FY, et al. Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 2010; 16: 1226-35.